Press

Press release

MAR | Successful rights issue enables increased
focus on strategic initiatives

 

The fourth quarter of 2019 was eventful, and we had the opportunity to see progress
in several areas. Importantly, we closed a rights issue of SEK 43 million, before
transaction costs, securing our ability to execute our plans and activities moving
forward.

PM_Acarix_YearEndReport_2019_eng

Acarix Year-end report 2019

PM_Acarix_YearEndReport_2019_sv

Acarix Bokslutkommunike 2019

 

 

About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.